PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-626.6	-559.02	-523.9	-438.16	-251.58	-128.08	-79	-142.11	-170.45	-93.75	Upgrade
Depreciation & Amortization	246.42	138.72	71.52	90.96	35.89	26.09	17.68	3.29	2.88	2.24	Upgrade
Share-Based Compensation	101.64	110.33	103.51	70.33	42.13	33.25	30.56	35.01	33.98	19.31	Upgrade
Other Operating Activities	120.13	-46.69	97.54	82.81	74.91	41.1	20.7	0.25	9.26	14.93	Upgrade
Operating Cash Flow	-158.42	-356.65	-251.33	-194.07	-98.64	-27.64	-10.06	-103.57	-124.34	-57.27	Upgrade
Capital Expenditures	-28.44	-32.02	-28.21	-17.84	-13.76	-7.1	-3.1	-1.78	-2.72	-4.66	Upgrade
Acquisitions	-89.59	-120.44	-57.22	-38.13	-35.68	-57.33	-77.16	0	0	0	Upgrade
Change in Investments	-58.71	442.64	304.61	-505.57	-337.8	21.81	93.38	106.26	-18.09	-140.5	Upgrade
Investing Cash Flow	-176.74	290.18	219.18	-561.55	-387.24	-42.61	13.12	104.48	-20.81	-145.17	Upgrade
Share Issuance / Repurchase	29.99	71.08	23.1	103.57	345.61	131.57	4.65	0.97	8.71	237.18	Upgrade
Debt Issued / Paid	-383.59	137.27	-2.22	-46.76	267.6	0	40	0	150	-0.05	Upgrade
Other Financing Activities	1,000	-40.4	-	611.9	-	-	-0.43	-	-4.65	-	Upgrade
Financing Cash Flow	646.4	167.95	20.88	668.72	613.21	131.57	44.22	0.97	154.06	237.13	Upgrade
Exchange Rate Effect	3.11	-2.77	-7.82	7.69	-1.3	-3.61	6.2	-1.58	-0.64	-0.35	Upgrade
Net Cash Flow	314.36	98.71	-19.09	-79.22	126.03	57.71	53.47	0.3	8.27	34.33	Upgrade
Free Cash Flow	-186.86	-388.67	-279.55	-211.91	-112.4	-34.74	-13.16	-105.34	-127.06	-61.94	Upgrade
Free Cash Flow Margin	-19.92%	-55.62%	-51.90%	-55.65%	-36.61%	-13.12%	-6.77%	-127.37%	-345.58%	-245.35%	Upgrade
Free Cash Flow Per Share	-2.50	-5.42	-3.97	-3.21	-1.91	-0.75	-0.34	-3.09	-3.78	-1.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).